News | Advanced Visualization | October 20, 2017

Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology

Funding will advance proprietary imaging technology designed to assess coronary artery disease with a machine learning algorithm

Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology

October 20, 2017 — Digital health company Analytics 4 Life announced it has completed a $25 million Series B financing. This financing event was supported by an international syndicate of accredited investors, including physicians, healthcare professionals and medical device experts. The company's novel cardiac imaging technology is under clinical investigation to help physicians assess the presence of coronary artery disease (CAD) using intrinsic signals scanned from the body without radiation, contrast agents or cardiac stress.

Current diagnostic methods for CAD are costly, risky and time-consuming. Analytics 4 Life seeks to address these challenges with its novel method of cardiac imaging. The company's technology represents a new approach to cardiac imaging based on advanced disciplines of mathematics and physics combined with the power of cloud computing and artificial intelligence. The first application of this technology is CorVista, a non-invasive, physician-directed diagnostic test that aims to identify the presence of CAD without radiation or cardiac stress.

CorVista is designed to scan signals naturally emitted by the body with a synchronous array of seven sensors on Analytics 4 Life's proprietary collection device. After the signals are acquired, the signal package is instantaneously transmitted to the cloud where it is analyzed by a machine-learned algorithm to generate a unique image and a heart model indicating areas of potential heart disease associated with the presence of CAD. The results of the test are displayed on a secure physician web portal that, in combination with a patient's medical history, risk factors and symptoms, are used by the interpreting physician to recommend further treatment.

A two-stage clinical trial at 13 sites in the United States is currently underway to support CorVista's development and regulatory filings. The ongoing study, with more than 2,000 patients enrolled so far, will measure the performance of a machine-learned algorithm for CAD detection to gold-standard cardiac catheterization results.  

Preliminary results will be presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference, Oct. 29-Nov. 2 in Denver. Assuming a positive U.S. Food and Drug Administration (FDA) review, the company anticipates having CorVista available in the U.S. next year.

For more information: www.analytics4life.com

Related Content

Nihon Kohden Launches Augmented Reality Electrophysiology Training App at HIMSS18
Technology | Advanced Visualization | March 06, 2018
Nihon Kohden announced the launch of the Nihon Kohden Dimensions Augmented Reality (AR) App to complement the Clinical...
NIH Issues $2.2 Million Grant for Augmented Reality Cardiac Hologram Research
News | Advanced Visualization | February 15, 2018
February 15, 2018 — The National Institutes of Health (NIH) awarded a $2.2 million research grant to healthcare techn
EchoPixel Showcases Next-Generation Surgical Planning With True 3-D Interactive Mixed Reality Software
News | Advanced Visualization | January 08, 2018
EchoPixel showcased the latest version of True 3D, its interactive, mixed reality software solution at the 103rd Annual...
Videos | Advanced Visualization | December 07, 2017
Dianna Bardo M.D., director of body MR and co-director of the 3-D Innovation Lab at Phoenix Children's Hospital, disc
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
December 4, 2017 — Vital Images unveiled the newest version of Vitrea...
Arterys Completes Series B to Accelerate Product Commercialization
News | Advanced Visualization | November 15, 2017
Arterys Inc. announced the close of its $30M Series B financing round. The investment was led by Temasek, with...
TeraRecon Introduces 175-Plus New Features in iNtuition 4.4.13
Technology | Advanced Visualization | November 06, 2017
November 6, 2017 — TeraRecton announced the launch of version 4.4.13 of its iNtuition...
TeraRecon Enhances Speed, Clinical Capabilities With Latest iNtuition Release
Technology | Advanced Visualization | October 25, 2017
October 25, 2017 — TeraRecon announced the release of version 4.4.13 of their iNtuition software, bringing over 175 n
Echopixel, True 3D Viewer, interactive virtual reality, pediatric surgery, increased clinical adoption
News | Advanced Visualization | March 21, 2017
March 21, 2017 — EchoPixel recently announced progress in the clinical adoption of its True 3D...
augmented reality, virtual reality, medical imaging, surgery, operating room

A 2-D view of what operators see when viewing actual 3-D medical images in the HoloLens augmented reality system using TeraRecon's new software.

Technology | Advanced Visualization | February 21, 2017
TeraRecon debuted their new high-performance, cloud-based augmented reality solution, the HoloPack Portal, at the 2017...
Overlay Init